Cleveland Clinic Cancer Center (Taussig) Outcomes
Colorectal Cancer
Colorectal Cancer Treatment Outcomes
Patients with gastrointestinal cancer benefit from the coordinated efforts of Cleveland Clinic's multidisciplinary teams, comprising surgeons and physicians from the departments of Colorectal Surgery and General Surgery, Gastroenterology, Interventional Radiology, Medical Oncology and Radiation Oncology. Tailored treatment regimens include adjuvant therapy following surgical resection for patients with tumors at risk for recurrence, as well as systemic therapies for patients with inoperable, incurable advanced disease. Clinical trials provide important treatment options to patients. The data shown here demonstrates superior outcomes in advanced-stage colorectal cancer.
Five-Year Overall Survival of Patients With All Stages of Colon and Rectum Cancer (N = 5676)
2011-2021
Five-Year Overall Survival of Patients With All Stages of Colon vs Rectal Cancer (N = 5685)
2011-2021
Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
---|---|---|---|---|---|
Colon (N = 3544) | 2642 | 1969 | 1412 | 1019 | 658 |
Rectum (N = 2141) | 1690 | 1272 | 915 | 656 | 421 |
Five-Year Overall Survival of Patients With Colon and Rectal Cancer by Stage (N = 5676)
2011-2021
Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
---|---|---|---|---|---|
Stage I (N = 998) | 787 | 648 | 510 | 385 | 248 |
Stage II (N = 1209) | 950 | 757 | 548 | 411 | 274 |
Stage III (N = 1940) | 1554 | 1197 | 888 | 641 | 414 |
Stage IV (N = 1155) | 773 | 464 | 267 | 148 | 83 |
Five-Year Overall Survival of Patients With Colon Cancer by Stage (N = 3334)
2011-2021
Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
---|---|---|---|---|---|
Stage I (N = 597) | 463 | 372 | 288 | 215 | 134 |
Stage II (N = 842) | 650 | 522 | 377 | 287 | 194 |
Stage III (N = 1052) | 834 | 661 | 512 | 371 | 240 |
Stage IV (N = 843) | 555 | 324 | 181 | 105 | 60 |
Five-Year Overall Survival of Patients With Rectal Cancer by Stage (N = 1976)
2011-2021
Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
---|---|---|---|---|---|
Stage I (N = 401) | 324 | 276 | 222 | 171 | 115 |
Stage II (N = 369) | 300 | 235 | 171 | 124 | 80 |
Stage III (N = 892) | 722 | 536 | 376 | 272 | 177 |
Stage IV (N = 314) | 218 | 140 | 86 | 43 | 23 |
Five-Year Overall Survival of Patients With All Stages of Colon and Rectal Cancer by Race (N = 5467)
2011-2021
Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
---|---|---|---|---|---|
Caucasian (N = 4874) | 3757 | 2824 | 2046 | 1486 | 952 |
African American (N = 593) | 421 | 297 | 212 | 146 | 100 |